Breathe Well Live Well
Lung Disease News |
Grazax for Childhood Asthma Nuetralizes Pollen, Could Hinder Disease Progression
Lung Disease News Study findings demonstrated that Grazax is effective for the treatment of asthma symptoms in kids. The medication also reduced grass and pollen allergy symptoms. Researchers measured direct reductions in immune system reactions in response to Grazax … |
View full post on asthma – Google News
|
New Data From GAP Landmark Trial Confirm GRAZAX® Prevents Asthma Symptoms in Children
PR Newswire (press release) The data, presented at the 2016 Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) in Vienna, confirm that GRAZAX® can prevent asthma symptoms, as well as offering sustained relief from grass allergy symptoms. |
View full post on asthma – Google News
|
New Data From GAP Landmark Trial Confirm GRAZAX® Prevents Asthma Symptoms in Children
PR Newswire UK (press release) ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today presented new data from the GRAZAX® Asthma Prevention (GAP) trial with GRAZAX®, ALK's allergy immunotherapy tablet against grass pollen allergy. The data, presented at the 2016 Annual Congress … |
View full post on asthma – Google News
|
ALK's Grazax in five-year landmark asthma prevention trial in children sees …
The Pharma Letter (registration) Denmark-based allergy specialist ALK Abello (ALKB: DC) has announced disappointing top-line results from the Grazax Asthma Prevention (GAP) trial with ALK's allergy immunotherapy tablet against grass pollen allergy. The GAP trial consisted of a … |
View full post on asthma – Google News
|
ALK's Grazax fails to prevent asthma, but reduces symptoms
PharmaTimes On the plus side, treatment with Grazax did have a positive effect on the children's asthma symptoms and use of asthma medication; the odds ratio for these at the end of the five-year evaluation period was 0.66 in favour of ALK's therapy, the firm said. |
View full post on asthma – Google News
|
ALK announces top-line results from the five-year landmark GRAZAX® Asthma …
GlobeNewswire (press release) The trial did not show an effect in terms of time to first diagnosis of reversible impairment of lung function. The trial demonstrated that GRAZAX® treatment significantly reduced the proportion of children experiencing asthma symptoms or using asthma … BRIEF-Alk Abello announces results from GRAZAX Asthma Prevention trial in children ALK announces top-line results from the five-year landmark GRAZAX(r) Asthma … |
View full post on asthma – Google News
Condition: Allergic Rhinitis
Interventions: Drug: Grazax; Drug: Placebo
Sponsor: ALK-Abelló A/S
Active, not recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days